Skolnick, et al., Trends in Biotech. 18(1):34-9, Jan. 2000.* |
Carter et al., DNA Cloning, VIII: A practical approach, Ed D.M. Glover, Chapter 7, pp. 141-161.* |
Uriel et al., Cancer Research 44(11):5314-5319, Nov. 1984.* |
Esteban et al., Leukemia 7(11):1807-1816, Nov. 1993.* |
Abramsky et al., “Alpha-fetoprotein Suppresses Experimental Allergic Encephalomyelitis,” Journal of Neuroimmunology 2:1-7 (1982). |
Abramsky et al., Annals New York Academy of Sciences, pp. 108-115 (1983). |
Aoyagi et al., “Differential Reactivity of α-Fetoprotein with Lectins and Evaluation of Its Usefulness in the Diagnosis of Hepatocellular Carcinoma”, Gann 75:809-815 (1984). |
Biddle et al., “Specific Cytoplasmic Alpha-fetoprotein Binding Protein in MCF-7 Human Breast Cancer Cells and Primary Breast Cancer Tissue,” Breast Cancer Research and Treatment 10:279-286 (1987). |
Boismenu et al., “Expression of Domains of Mouse Alpha-Fetoprotein in Escherichia coli,” Life Sciences 43:673-681 (1988). |
Bowie et al., “Deciphering the Message In Protein Sequences: Tolerance to Amino Acid Substitutions,” Science 87:1306-1310 (1990). |
Brenner et al., “Influence Of Alpha-fetoprotein On the In Vitro and in Vivo Immune Responses to Acetylcholine Receptor,” Annals New York Academy of Sciences 377:208-221 (1981). |
Brenner et al., “Inhibitory Effect Of α-fetoprotein On the Binding of Myasthenia Gravis Antibody to Acetylcholine Receptor,” Proc. Natl. Acad. Sci. USA 77:3635-3639 (1980). |
Brenner et al., “Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Alpha-Fetoprotein Rich Formation,” Immunology Letters 3:163-167 (1981). |
Buamah et al., “Serum Alpha Fetoprotein Heterogeneity As A Means Of Differentiating Between Primary Hepatocellular Carcinoma And Hepatic Secondaries,” Clinica Chimica Acta. 139:313-316 (1984). |
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue,” J. Cell. Biol. 111:2129-2138 (1990). |
Buschman et al., “Experimental Myasthenia Gravis Induced in Mice by Passive Transfer of Human Myasthenic Immunoglobulin,” Journal of Neuroimmunology, 13:315-330 (1987). |
Cohen et al., “Suppression by Alpha-Fetoprotein of Murine Natural Killer Cell Activity Stimulated in Vitro and in Vivo by Interferon and Interleukin 2,” Scand. J. Immunol. 23:211-223 (1986). |
Dattwyler et al., “Binding Of α-foetoprotein To Murine T cells,” Nature 256:656-657 (1975). |
Gershwin et al., “The Influence of α-Fetoprotein on Moloney Sarcoma Virus Oncogenesis: Evidence for Generation of Antigen Nonspecific Suppressor T Cells,” The Journal of Immunology 121:2292-2297 (1978). |
Giuliani et al., “Synthesis And Characterization Of A Recombinant Fragment Of Human α-fetoprotein With Antigenic Selectivity Versus Albumin,” Protein Engineering 2:605-610 (1989). |
Glazier et al., “Graft-Versus-Host Disease in Cyclosporin A-Treated Rats After Syngeneic and Autologous Bone Marrow Reconstitution,” J. Exp. Med. 158:1-8 (1983). |
Goidl et al., “Studies On The Mechanisms of Alpha-Fetoprotein Induction of Immune Suppressive Activity,” Developmental Immunobiology pp. 35-55 (1979). |
Hamel et al., “Phenotype and Function of Bone Marrow-Derived T- and Non-T-Cells Activated In Vitro By Alpha-Fetoprotein,” In: Biological Activities of Alpha-Fetoprotein (vol. 1), Mizejewski, G.J. and Jacobson, H.I (eds.), CRC Press, Inc. (Boca Raton, FL), pp. 167-177 (1987). |
Heyward et al., “Early Detection Of Primary Hepatocellular Carcinoma By Screening For Alpha-Fetoprotein in High-Risk Families,” The Lancet 2:1161-1162 (1983). |
Hooper et al., “Human AFP Inhibits Cell Proliferation and NK-Like Cytotoxic Activity Generated in Autologous, But Not In Allogeneic Mixed Lymphocyte Reactions,” In: Biological Activities of Alpha-Fetoprotein, (vol. II) Mizejewski, G.J. and Jacobson, H.I. (eds.), CRC Press, Inc. (Boca Raton, FL), pp. 183-187 (1989). |
Hooper, et al., “Selective Inhibition of Murine T-Cell Proliferation And Lymphokine-Activated Natural Killer Cell Function By alpha-Fetoprotein, In: Biological Activities of Alpha-Fetoprotein,” (vol. 1) Mizejewski, G.J. and Jacobson, H.I (eds.), CRC Press, Inc. (Boca Raton, FL), pp. 153-165 (1987). |
Hooper et al., “Regulation of Murine T-Cell Responses to Autologous Antigens by α-Fetoprotein,” Cellular Immunology 63:417-425 (1981). |
Hooper et al., “Suppression Of Primary And Secondary Autologous Mixed Lymphocyte Reactions By Murine Alphafetoprotein,” Oncodevelopmental Biology and Medicine 3:151-160 (1982). |
Hoskin et al., “In Vitro Activation of Bone Marrow-Derived T- and Non-T-Cell Subsets by α-Fetoprotein,” Cellular Immunology 96:163-174 (1985). |
Hoskin et al., “Specific maternal and anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors,” Clin. exp. Immunol. 76:262-267 (1989). |
Hoskin et al., “Analysis of Pregnancy-Associated Immunoregulatory Pathways,” In: Alpha-Fetoprotein and Congenital Disorders, Academic Press, Inc. (New York), pp. 59-78 (1985). |
Innis et al., “Amplification of α-Fetoprotein Complementary DNA by Insertion into a Bacterial Plasmid,” Archives of Biochemistry and Biophysics 195:128-135 (1979). |
Ishiguro et al., “Serum Alpha-Fetoprotein Subfractions in Patients With Primary Hepatoma or Hepatic Metastasis of Gastric Cancer,” Cancer 55:156-159 (1985). |
Jacobson et al., “Inhibition of Estrogen-dependent Breast Cancer Growth by a Reaction Product of α-Fetoprotein and Estradiol,” Cancer Research 50:415-420 (1990). |
Jiang et al., “Role of CD8+ T Cells In Murine Experimental Allergic Encephalomyelitis,” Science 256:1213-1215 (1992). |
Keller et al., “Immunosuppressive Properties of AFP: Role Of Estrogens,” In: Onco-Developmental Gene Expression, Fishman, W.H. and Sell, S. (eds.), Academic Press, Inc. (New York) pp. 287-295 (1976). |
Kikutani et al., “The Murine Autoimmune Diabetes Model: NOD and Related Strains,” Advances in Immunology 51:285-322 (1992). |
Kumar et al., “Amino Acid Variations At A Single Residue In An Autoimmune Peptide Profoundly Affect Its Properties: T-cell Activation, Major Histocompatibility Complex Binding, and Ability To Block Experimental Allergic Encephalomyelitis,” PNAS 1306-1310 (1990). |
Lazar et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities,” Mol. Cell. Biol. 3:1247-1252 (1988). |
Line et al., “Medical Potential Of AFP As A Tumor Imaging Agent,” In: Biological Activities of Alpha-Fetoprotein (vol. II), Mizejewski, G.J. and Jacobson, H.I (eds.), CRC Press, Inc. (Boca Raton, FL) pp. 139-148 (1989). |
Lu et al., “α-Fetoprotein Inhibits Macrophage Expression Of Ia Antigens,” The Journal of Immunology 132:1722-1727 (1984). |
Masuda et al., “Selective Antitumor Effect of Thioether-Linked Immunotoxins Composed of Gelonin and Monoclonal Antibody to Alpha-Fetoprotein or Its F(ab′)2 Fragment,” Tumor Biol. 15:175-183 (1994). |
Mizejewski et al., “Alpha Fetoprotein Testing: Regulatory and Technical Considerations,” Laboratory Management (1987). |
Morinaga et al., “Primary Structures Of Human α-fetoprotein And Its mRNA,” Proc. Natl. Acad. Sci. USA 80:4604-4608 (1983). |
Moro et al., “Monoclonal Antibodies Directed against a Widespread Oncofetal Antigen: The Alpha-Fetoprotein Receptor,” Tumor Biol. 14:116-130 (1993). |
Murgita et al., “Selective Immunoregulatory Properties Of α-Fetoprotein,” La Ricerca Clin. Lab. 9:327-342 (1979). |
Murgita et al., “Regulation of Immune Functions in the Fetus and Newborn,” Progress Allergy 29:54-132 (1981). |
Murgita et al., “Suppression Of The Immune Response By α-Fetoprotein,” The Journal of Experimental Medicine 141:440-452 (1975). |
Murgita et al., “Suppression Of The Immune Response By α-Fetoprotein,” The Journal of Experimental Medicine 141:269-286 (1975). |
Murgita et al., “Adult murine T cells Activated in vitro By α-fetoprotein And Naturally Occurring T cells In Newborn Mice: Identity In Function And Cell Surface Differentiation Antigens,” Proc. Natl. Acad. Sci. USA 75:2897-2901 (1978). |
Murgita et al., “Effects Of Human Alpha-foetoprotein On Human B and T Lymphocyte Proliferation in vitro,” Clin. Exp. Immunol. 33:347-356 (1978). |
Murgita et al., “The Effects of Mouse Alpha-Fetoprotein on T-Cell-Dependent and T-Cell-Independent Immune Responses In Vitro,” Scand. J. Immunol. 5:1215-1220 (1976). |
Murgita et al., “The Immunosuppressive Role of Alpha-Feto-protein During Pregnancy,” Scand. J. Immunol. 5:1003-1014 (1976). |
Murgita et al., “α-Fetoprotein Induces Suppressor T Cells in vitro,” Nature 267:257-258 (1977). |
Murgita et al., “Characterization Of Murine Newborn Inhibitory T Lymphocytes: Functional And Phenotype Comparison With An Adult T Subset Activated in vitro By Alpha-fetoprotein,” Eur. J. Immunol. 11:957-964 (1981). |
Nelson et al., “Maternal-Fetal Disparity in HLA Class II Alloantigens And The Pregnancy-Induced Amelioration of Rheumatoid Arthritis,” The New England Journal of Medicine 329:466-471 (1993). |
Nishi et al., “Expression of Rat α-Fetoprotein cDNA in Escherichia coli and in Yeast,” J. Biochem. 104:968-972 (1988). |
O'Neill et al., “Regulation Of Human Lymphocyte Activation By Alpha-Fetoprotein: Evidence For Selective Suppression Of Ia-Associated T-Cell Proliferation In Vitro,” Oncodevelopmental Biology and Medicine 3:135-150 (1982). |
Peck et al., “Cellular And Genetic Restrictions In The Immunoregulatory Activity Of α-Fetoprotein,” The Journal of Immunology 128:1134-1140 (1982). |
Peck et al., “Cellular And Genetic Restrictions In The Immunoregulatory Activity Of Alpha-Fetoprotein,” The Journal of Experimental Medicine 147:667-683 (1978). |
Peck et al., “Cellular And Genetic Restrictions In The Immunoregulatory Activity Of Alpha-Fetoprotein,” J. Exp. Med. 148:360-372 (1978). |
Salgaller et al., “Generation Of Specific Anti-melanoma Reactivity By Stimulation Of Human Tumor-infiltrating Lymphocytes With MAGE-1 Synthetic Peptide,” Immunol. Immunother. 39:105-116 (1994). |
Sell, “Alphafetoprotein,” In: Cancer Markers Diagnostic and Developmental Significance, Sell, S., (ed.), Humana Press, Clifton, NJ pp. 249-293 (1980). |
Semeniuk et al., “Immunoregulation By Recombinant Alpha-Fetoproteins Produced In Eukaryotic And Prokaryotic Expression Systems,” Abstract 2799, Experimental Biology 94™, Anaheim, CA (1994). |
Soto et al., “Control Of Growth Of Estrogen-sensitive Cells: Role For α-fetoprotein,” Proc. Natl. Acad. Sci. USA 77:2084-2087 (1980). |
van Oers et al., “Analytical- And Preparative-Scale Separation Of Molecular Variants of α-Fetoprotein By Anion-Exchange Chromatography On Monobead™ Resins,” Journal of Chromatography 525:59-69 (1990). |
van Oers et al., “Isolation And Characterization Of A Distinct Immunoregulatory Isoform Of α-Fetoprotein Produced By The Normal Fetus,” J. Exp. Med. 170:811-825 (1989). |
Villacampa et al., “Alpha-Fetoprotein Receptors In A Human Breast Cancer Cell Line,” Biochemical and Biophysical Research Communications 122:1322-1327 (1984). |
Yamamoto et al., “Expression Of Human α-Fetoprotein In Yeast,” Life Sciences 46: 1679-1686 (1990). |